Pure Global

AFIAS Total Anti-Infliximab - India CDSCO Medical Device Registration

AFIAS Total Anti-Infliximab is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_d92470da30e4d28177b85829f3cbea5f_7f3ea937210318d24889b872b790ddb1. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
AFIAS Total Anti-Infliximab
UID: IMP/IVD/2021/000365_d92470da30e4d28177b85829f3cbea5f_7f3ea937210318d24889b872b790ddb1

Brand Name

AFIAS Infliximab

Device Class

Class B

Approving Authority

CDSCO

Product Information

AFIAS Total Anti-Infliximab is a fluorescence Immunoassay (AFIAS Infliximab ) for the semi-quantitative determination of free and bound antibodies against infliximab in human serum/plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing